Company data
Cullinan Therapeutics, Inc. employees and revenue per employee
CGEM · Biotechnology · $954M market cap
Cullinan Therapeutics, Inc. had 31 employees at the end of fiscal Dec 2021. Revenue for the year was $18.9M, or $611K per employee.
The latest annual report we hold is more than two years old, so these numbers may be out of date.
Employees
31
Revenue
$18.9M
Revenue / employee
$611K
Peer median $459K
Rank in industry
47 of 109
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Only one fiscal year on file so far, so there is no trend to draw yet.
Cullinan Therapeutics, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| CGEM Cullinan Therapeutics, Inc. | 31 | $18.9M | $611K | — |
| OBIO Orchestra BioMed Holdings, Inc. | 86 | $33.5M | $389K | Efficient growth |
| VSTM Verastem, Inc. | 102 | $30.9M | $303K | Efficient growth |
| CBIO Crescent Biopharma, Inc. | 44 | $10.8M | $246K | — |
| CAPR Capricor Therapeutics, Inc. | 160 | $22.3M | $139K | Hiring into decline |
| ALMS Alumis Inc. | 221 | $24.1M | $109K | — |
| JANX Janux Therapeutics, Inc. | 109 | $10.0M | $92K | Hiring into decline |
| RLAY Relay Therapeutics, Inc. | 192 | $15.4M | $80K | Leaner |
| ZBIO Zenas BioPharma, Inc. | 167 | $10.0M | $60K | Efficient growth |
Questions about Cullinan Therapeutics, Inc.
- How many employees does Cullinan Therapeutics, Inc. have?
- Cullinan Therapeutics, Inc. reported 31 employees for the fiscal year ending Dec 2021, in the annual report it filed on March 17, 2022.
- What is Cullinan Therapeutics, Inc.'s revenue per employee?
- Cullinan Therapeutics, Inc. brought in $18.9M of revenue in fiscal Dec 2021, which is $611K per employee. That ranks 47 of 109 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare CGEM with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Cullinan Therapeutics, Inc.'s annual reports (Form 10-K), latest filed March 17, 2022. This is data, not a recommendation to buy or sell CGEM.